(Q46438797)

English

Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid

scientific article published on 9 August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

0 references

Athanasios Dimopoulos

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

Efstathios Kastritis

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

E Eleftherakis-Papaiakovou

8

object named as

E Eleftherakis-Papaiakovou

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

author name string

C Bamia

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

I Melakopoulos

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

D Gika

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

M Roussou

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

M Migkou

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

D Christoulas

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

E Terpos

10

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

A Bamias

11

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

publication date

9 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

20

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

117-120

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

Bisphosphanates and Oral Cavity Avascular Bone Necrosis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

Osteonecrosis of the jaw and bisphosphonates

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

Osteonecrosis of the jaw related to the use of bisphosphonates.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN554

21 January 2018

Identifiers

10.1093/ANNONC/MDN554

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18689864

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46438797&oldid=2111727597"